by John Nycz | May 16, 2020 | Diagnostics
“To date, no human reinfections have been observed.” Will COVID-19 Produce a Durable Immune Response? The latest from CDC researchers and physicians as published May 11, 2020 in JAMA. In spite of no known reinfections, the body of evidence is still...
by John Nycz | May 14, 2020 | Diagnostics
U.S. based physicians and scientists from 57 institutions and 46 states have banded together. On their own. Here’s the leadership — it’s impressive: COVID-19 Convalescent Plasma Project (CCPP19) Leadership Group Arturo Casadevall MD, PhD (Chair),...
by John Nycz | May 7, 2020 | Diagnostics
As we at the FDA have said before, every step we have taken in our approach to COVID-19 testing has been a careful balancing of risks and benefits – all done to anticipate and meet continuing and evolving public health needs as we combat this virus. That’s why today...
by John Nycz | Mar 25, 2020 | Uncategorized
Testing for COVID-19 antibodies may be the most important part of getting accurate data about how many people have actually been exposed. Recent tests of sample population in California indicate the number asymptomatic and mildy symptomatic undetected cases could...
Recent Comments